MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Reproductive factors influence on cognitive function of Parkinson’s disease in female patients-from a cross-sectional study

    Y. Wu, H. Liu, R.W. Ou, Q.Q. Wei, H.F. Shang (Chengdu, People’s Republic of China)

    Objective: To explore the relationship between the female reproductive factors and cognitive decline/dementia with PD Background: Cognitive dysfunction was the common non-motor features of Parkinson’s…
  • 2018 International Congress

    Dual task walking differentially affects toe clearance in Lewy body disease: A contributor to dynamic falls risk?

    L. Alcock, R. McArdle, L. Aubrook, B. Galna, A. Thomas, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: To evaluate the change in gait and minimum toe clearance when walking under dual task in different dementia sub-types as a contributor to dynamic…
  • 2018 International Congress

    Levels of plasma alpha-synuclein as measured using Single Molecule Array technology is higher in Parkinson’s disease compared to controls and is not influenced by LRRK2 genotype

    YJ. Tan, A. Ng, ZH. Lu, S. Ng, E. Ng, F. Setiawan, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: To investigate plasma alpha-synuclein levels in PD using ultra-sensitive protein detection technology, and to determine the association of plasma alpha-synuclein with cognitive, motor and…
  • 2018 International Congress

    Categorising visual hallucinations in early Parkinson’s disease

    B. Clegg, G. Duncan, T. Khoo, R. Barker, D. Burn, A. Yarnall, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To categorise visual hallucinations (VHs) in a cohort of newly diagnosed Parkinson’s disease (PD) patients and determine associations with clinical characteristics. Background: Visual hallucinations…
  • 2018 International Congress

    Expanding the clinical phenotype of BPAN: A case report

    M. Boca, A. Herwadkar, C. Breen, M. Silverdale, C. Kobylecki (Salford, United Kingdom)

    Objective: To describe an atypical presentation of a rare NBIA disorder Background: Beta-propeller protein-associated neurodegeneration (BPAN) manifests in infancy as an initially static encephalopathy with…
  • 2018 International Congress

    Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore cognitive and behavioural disturbances between subtypes of progressive supranuclear palsy (PSP). Background: Although clinical diagnosis of PSP is based on specific motor symptoms,…
  • 2018 International Congress

    Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

    K. Ohta, T. Nakajima (Niigata, Japan)

    Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…
  • 2018 International Congress

    A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

    E. Cinar, G. Yalcin-Cakmakli, E. Saka, A. Ulusoy, B. Tel, B. Elibol (Ankara, Turkey)

    Objective: Our aim is to model cognitive dysfunction of Parkinson's disease (PD) together with motor deficits by targeted overexpression of alpha-synuclein (a-syn) in bilateral dentate…
  • 2018 International Congress

    Turning during gait is associated with gray matter density of the nucleus basalis of Meynert in Parkinson’s disease

    R. Morris, T. Madhyastha, D. Martini, K. Smulders, J. Quinn, V. Kelly, K. Edwards, C. Zabetian, T. Grabowski, F. Horak (Portland, OR, USA)

    Objective: To examine whether turning during gait is associated with gray matter (GM) density of the nucleus basalis of Meynert (nbM) and attention in people…
  • 2018 International Congress

    Association between MAPT haplotype and hippocampal repetition suppression in Parkinson’s disease

    E. Yoon, T. Alrazi, M. Ramezani, I. Kathol, J. Sarna, T. Hammer, L. Derwent, J. Cheetham, Z. Gan-Or, G. Rouleau, O. Monchi (Calgary, AB, Canada)

    Objective: We aimed to explore the relationship between the microtubule-associated tau gene (MAPT) haplotypes and response in the hippocampus to repeated stimuli in Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley